Results50 per page · sorted by obligated FY2024+
| Award | Company | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|---|
| W81XWH20C0088 definitive contract | Vascular Solutions LLC | $1.9M | Freeze dried plasma commercial viability activities | Defense Health Agency | Health R&D | Sep 8, 2025 DoD 90d |
| W81XWH13C0115 definitive contract | CACI Photonics, LLC | -$17K | Army sbir phase i proposal a123-117-0059 | Army | Health R&D | Jan 10, 2025 DoD 90d |
| W911QY14C0082 definitive contract | Infrascan Inc | -$18K | Igf::ot::igf research and development | Defense Contract Management Agency | Health R&D | Jul 22, 2024 DoD 90d |
| W81XWH20C0100 definitive contract | Teva Pharmaceuticals USA, Inc | -$41K | Adenovirus vaccine efficiency study. | Defense Health Agency | Health R&D | Jan 22, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters by company, agency, category and date, with CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial